Related Experiment Video
Updated: May 7, 2026

Myocardial Infarction and Functional Outcome Assessment in Pigs
Published on: April 25, 2014
Sudden death after myocardial infarction
A Selcuk Adabag1, Terry M Therneau, Bernard J Gersh
1Division of Cardiology, Veterans Affairs Medical Center, Minneapolis, Minnesota, USA.
Insights
Sudden cardiac death risk after myocardial infarction (MI) has decreased over 30 years. Heart failure significantly increases this risk, while recurrent ischemia does not, according to a community study.
Area of Science:
- Cardiology
- Public Health
- Epidemiology
Background:
- Sudden cardiac death (SCD) risk post-myocardial infarction (MI) requires updated community assessment.
- Recurrent ischemia and heart failure's impact on SCD post-MI is not well-understood.
Purpose of the Study:
- To assess SCD risk following MI in a community setting.
- To determine the influence of recurrent ischemia and heart failure on SCD risk.
Main Methods:
- A population-based surveillance study of 2997 MI patients in Olmsted County, Minnesota (1979-2005).
- Follow-up through 2008 with SCD defined as out-of-hospital death from coronary disease.
- Comparison of observed survival with expected survival rates.
Main Results:
- SCD incidence was 1.2% at 30 days and 6.9% at 5 years, significantly higher than expected.
- SCD risk has declined significantly over time (HR 0.62 for 1997-2005 vs. 1979-1987).
- Heart failure markedly increased SCD risk (HR 4.20), while recurrent ischemia did not (HR 1.26).
Conclusions:
- The risk of SCD after MI has significantly decreased in community practice over 30 years.
- Heart failure is an independent risk factor for SCD post-MI.
- Recurrent ischemia is not independently associated with increased SCD risk post-MI.
Context:
Sudden cardiac death after myocardial infarction (MI) has not been assessed recently in the community. Risk stratification for sudden cardiac death after MI commonly relies on baseline characteristics and little is known about the relationship between recurrent ischemia or heart failure and sudden cardiac death.
Objective:
To evaluate the risk of sudden cardiac death after MI and the impact of recurrent ischemia and heart failure on sudden cardiac death.
Design, Setting, And Participants:
Population-based surveillance study of 2997 residents (mean [SD] age, 67 [14] years; 59% were men) experiencing an MI in Olmsted County, Minnesota, between 1979 and 2005, and followed up through February 29, 2008.
Main Outcome Measures:
Sudden cardiac death defined as out-of-hospital death due to coronary disease; and observed survival free of sudden cardiac death compared with that expected in Olmsted County, Minnesota.
Results:
During a median follow-up of 4.7 years (25th-75th percentile, 1.6-7.1 years), 1160 deaths occurred, 282 from sudden cardiac death (24%). The 30-day cumulative incidence of sudden cardiac death was 1.2% (95% confidence interval [CI], 0.8%-1.6%). Thereafter, the rate of sudden cardiac death was constant at 1.2% per year yielding a 5-year cumulative incidence of 6.9% (95% CI, 5.9%-7.9%). The 30-day incidence of sudden cardiac death was 4-fold higher than expected (standardized mortality ratio, 4.2; 95% CI, 2.9-5.8). The risk of sudden cardiac death has declined significantly over time (hazard ratio [HR], 0.62 [95% CI, 0.44-0.88] for MIs that occurred between 1997 and 2005 compared with between 1979 and 1987; P = .03). The recurrent events of ischemia (n = 842), heart failure (n = 365), or both (n = 873) occurred in 2080 patients. After adjustment for baseline characteristics, recurrent ischemia was not associated with sudden cardiac death (HR, 1.26 [95% CI, 0.96-1.65]; P = .09), while heart failure markedly increased the risk of sudden cardiac death (HR, 4.20 [95% CI, 3.10-5.69]; P < .001).
Conclusions:
The risk of sudden cardiac death following MI in community practice has declined significantly over the past 30 years. Sudden cardiac death is independently associated with heart failure but not with recurrent ischemia.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis I: Introduction
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Introduction Cardiac Emergencies

